febuxostat has been researched along with Dermatitis Medicamentosa in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, PH; Chen, WW; Hsiao, FY; Huang, WI; Lin, CW | 1 |
| Chang, JY; Chin, SW; Chu, MT; Chung, WH; Huang, YL; Hung, SI; Pan, RY; Wang, WC | 1 |
| Bardin, T; Chalès, G; Clerson, P; Delayen, A; Flipo, RM; Korng Ea, H; Pascart, T; Roujeau, JC | 1 |
| Haruyama, S; Nakamura, M; Nishio, D; Oda, T; Ohmori, S; Omoto, D; Sawada, Y; Yoshioka, M | 1 |
| Dalbeth, N; Stamp, L | 1 |
1 review(s) available for febuxostat and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution.
Topics: Allopurinol; Asymptomatic Diseases; Drug Eruptions; Drug Hypersensitivity; Febuxostat; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Uricosuric Agents; Urolithiasis | 2017 |
4 other study(ies) available for febuxostat and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real-world patients: A nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Child; Child, Preschool; Cohort Studies; Drug Eruptions; Febuxostat; Female; Gout; Gout Suppressants; Humans; Infant; Infant, Newborn; Interrupted Time Series Analysis; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2019 |
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Case-Control Studies; Cells, Cultured; Cross Reactions; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Febuxostat; Female; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Oxypurinol; Reference Values; Stevens-Johnson Syndrome; Thiazoles | 2015 |
Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment.
Topics: Aged; Allopurinol; Drug Eruptions; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Retrospective Studies | 2016 |
Fixed drug eruption-like macules caused by febuxostat.
Topics: Adult; Drug Eruptions; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia | 2016 |